LOX and carcinoma: Furthermore, although we have not observed an overrepresentation of cases with positive LOX expression in carcinomas compared to nodular prostate hyperplasia, the LOX immunoreactivity score was significantly higher in organ confined prostate carcinomas compared to nodular prostate hyperplasia.